Background and introduction {#s1}
===========================

Population-level health interventions aim to improve health by changing underlying social, economic and environmental conditions, or by directly influencing health behaviours. They may be specific to healthcare or involve the regulation of or changes to sectors such as education, transport, housing or employment. Often, randomised approaches to evaluation are not possible for population-level health interventions for practical, political or ethical reasons, for example, where a smoking ban is introduced across the entire population of a country. Non-randomised approaches using observational data are, therefore, the only methods left open to evaluators. Providing that suitable methods have been adopted to ensure the internal validity of the study, observational studies have much to contribute.

In order to minimise bias (ie, the risk that the effect seen is due to factors other than the intervention), many studies use a control group or counterfactual. In establishing a counterfactual, different study designs use different methods to mimic the trend in the outcome variable in the absence of the intervention. Some methods, such as direct matching and propensity score matching, select controls based only on observed characteristics. Regression discontinuity analysis uses individuals on the opposite side of a cut-off as the control group, while the instrumental variable technique uses a variable that influences the explanatory variable but not the dependent variable, thereby allowing a researcher to separate the intervention effect. Other approaches, such as uncontrolled 'before and after' approaches, rely on the assumption that the previous trend in the treated unit would have continued but for the intervention only. Here, the modelled continuation of the pretrend is the counterfactual. When a control unit is added, the change in the treated unit is compared with the change in the control in what is known as a 'difference in difference' (DiD) approach. DiD estimates the treatment effect by taking the difference between the change in the treated unit and the change in the control units in the periods before and after the intervention. Provided that treated and control units had parallel pretreatment trends, and there were no other events affecting one unit but not the other, a constant difference would be expected to continue in the postintervention period. If the difference between the treated and control unit changes in the postintervention period, this can be interpreted as a treatment effect. If pretreatment trends are not parallel, or an event occurred that affected only one of the units, some of the difference between the units will be the difference in the trend rather than the effect of the intervention, and the estimate of the treatment effect will be biased.

It is sometimes difficult to establish whether the parallel trends assumption is met and whether the control group is a sufficiently accurate representation of what would have happened in the treated area without the intervention. Synthetic control methodology (SCM) allows the construction of a counterfactual by selecting a weighted average of the outcome variable from a group of units similar to the treated unit.

Abadie and Gardeazabal[@R1] first set out SCM in a study looking at the impact of terrorism on the economy of the Basque region of Spain. Abadie *et al* [@R2] followed this with a study examining the impact of California's 1988 tobacco control programme, and statistical packages (in Stata, R and Matlab) to support the implementation of the method were released in 2011. A further overview of the method and case study looking at the economic impact on West Germany of reunification in 1990[@R3] was published in 2015 and is a useful source of reference.

The aims of this article are to introduce SCM to researchers in public health, to set out the uses of SCM in health as identified by our review and to provide a step-by-step guide to implementation and case study with syntax and data (adapted from Abadie *et al* [@R3]).

Method {#s2}
======

We undertook a wide-ranging literature review in February 2016 searching the term 'synthetic control method' or 'synthetic control' in 26 health, social science and grey literature databases (see online [supplementary material 1](#SP1){ref-type="supplementary-material"}). Key authors and citations of key articles were also searched. No restrictions were placed on language or date. The only inclusion criterion was that the article described an application of SCM.
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Results {#s3}
=======

First, we summarise examples of the use of SCM in health research as identified in our review, we then set out the steps in conducting an SCM study and outline the advantages, assumptions and limitations of the method. In online [supplementary material 2](#SP2){ref-type="supplementary-material"}, we present a further case study of German reunification, this time looking at its impact on life expectancy, we illustrate the method set out in those articles in straightforward steps. We use Stata V.14 and synth for Stata. Data and syntax are provided in online [supplementary material 3](#SP3 SP4){ref-type="supplementary-material"}.
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Use of SCM in health {#s3a}
--------------------

[Table 1](#T1){ref-type="table"} sets out the exposures and outcomes, settings and study level of 38 health-related studies using the synthetic control method identified in the literature review[@R2] (and the unpublished Mas N, Friedman J and Figallo M. Can integrated primary and hospital care improve both quality and efficiency outcomes in health care? Evidence from a Spanish Public private partnership (2015) (permission to quote granted)).

###### 

Health-related studies using synthetic control methodology

  Date                                       First author (reference)   Exposure                                   Outcome                                     Treated unit(s)                                     Donor pool
  ------------------------------------------ -------------------------- ------------------------------------------ ------------------------------------------- --------------------------------------------------- ------------------------------------------------------------------------
  Health finance and health systems reform                                                                                                                                                                         
  2016                                       Ryan[@R4]                  Pay for performance                        Mortality                                   UK                                                  Other high-income countries
  2015                                       Mas (unpublished)          Healthcare integration                     Healthcare efficiency measures              Spanish integrated healthcare unit                  Spanish non-integrated healthcare units
  2015                                       Lepine[@R5]                User fee removal                           Healthcare utilisation                      Treated Zambian regions                             Untreated Zambian regions
  2015                                       Kreif[@R6]                 Pay for performance                        Risk adjusted mortality                     Treated UK hospitals                                Untreated UK hospitals
  2015                                       Machado[@R7]               Levels of health insurance                 Infertility levels                          States with strong infertility mandates             States with weak infertility mandates
  2015                                       Roy[@R8]                   Health reform                              Sources of health insurance                 Insured Massachusetts Population                    Uninsured Massachusetts population
  2014                                       Courtemanche[@R9]          Levels of health insurance                 Self-reported health                        Massachusetts                                       Untreated US states
  2014                                       Dunn[@R10]                 Health reform                              Physician payments                          Massachusetts                                       Untreated US states
  2014                                       Tuzemen[@R11]              Health reform                              Non-insurance rate                          Massachusetts                                       Untreated US states
  2013                                       Lo[@R12]                   Income levels                              Substitution of public/private insurance    Illinois                                            Untreated US states
  Industry regulation                                                                                                                                                                                              
  2016                                       Quast[@R13]                Registration of sex workers                Incidence of sexually transmitted disease   Tijuana, Mexico                                     Untreated Mexican regions
  2015                                       Restrepo[@R14]             Trans fat ban                              Heart disease mortality                     Treated counties in New York                        Untreated counties in New York
  2014                                       Sampaio[@R15]              Mobile phone ban                           Road accidents                              New York state                                      Untreated US states
  2014                                       Restrepo[@R16]             Trans fat ban                              Heart disease mortality                     Denmark                                             Other OECD countries
  2014                                       Green[@R17]                Alcohol licencing hours                    Road accidents                              England and Wales                                   Scottish regions
  2014                                       Wang[@R18]                 Pasteurisation of milk                     Child mortality                             Treated US cities                                   Untreated US cities
  2014                                       Cunningham[@R19]           Decriminalisation of indoor prostitution   Incidence of sexually transmitted disease   Rhode Island, USA                                   Untreated US states/cities
  Taxation policy                                                                                                                                                                                                  
  2016                                       Berardi[@R20]              Tax on sugary drinks                       Price of affected drink categories          Prices of sugary drinks in France                   Other drink categories in France
  2016                                       Grogger[@R21]              Tax on sugary drinks                       Price of other drink categories             Prices of sugary drinks in Mexico                   Other drink categories in Mexico
  2016                                       Chelwa[@R22]               Tax on cigarettes                          Cigarette sales                             South Africa                                        Untreated low-income and middle-income countries
  2015                                       Bilgel[@R23]               Tax breaks for organ donors                Live organ donations                        New York State                                      Untreated US states
  2015                                       Fletcher[@R24]             Tax on sugary drinks                       Changes in BMI                              Arkansas, Ohio                                      Untreated US states
  2010                                       Abadie[@R2]                Tax on cigarettes                          Cigarette sales                             California                                          Untreated US states
  Legal changes                                                                                                                                                                                                    
  2015                                       Zabinski[@R25]             Medical malpractice liability              Patient safety measures                     Texas, Florida, Illinois, South Carolina, Georgia   Untreated US states
  2015                                       Crifasi[@R26]              Hand gun laws                              Suicide rates                               Connecticut, Missouri                               Untreated US states
  2015                                       Cunningham[@R27]           Drug laws                                  Drug seizures                               Mississippi                                         Untreated US states
  2015                                       Powell[@R28]               Legalisation of marijuana                  Overdoses from painkillers                  US states with medical marijuana law                US states without medical marijuana law
  Development and barriers to development                                                                                                                                                                          
  2015                                       Alavuotunki[@R29]          General Budget Support (GBS)               Neonatal mortality                          Countries in receipt of GBS                         Countries from the region of the treated country not in receipt of GBS
  2015                                       Karlsson[@R30]             HIV prevalence                             Demographic outcomes                        Countries in Africa with high HIV prevalence        Countries in Africa with low HIV prevalence
  2014                                       Pereda[@R31]               Climate change                             Dengue risk                                 Brazilian cities with high dengue risk              Brazilian cities with low dengue risk
  2014                                       Peiters[@R32]              Political transition                       Child mortality                             Countries which became democratic                   Countries that remained autocratic
  Nutrition interventions                                                                                                                                                                                          
  2015                                       Qian[@R33]                 School food programme                      BMI                                         Treated schools in Arkansas, US                     Untreated schools in Arkansas, USA
  2014                                       Bauhoff[@R34]              School food programme                      BMI                                         Treated school districts in California, US          Untreated school district in California, USA
  2013                                       Kiesel[@R35]               Better food labelling                      Product sales                               Treated US supermarkets                             Untreated US supermarkets
  Welfare reforms                                                                                                                                                                                                  
  2016                                       Chung[@R36]                Money transfer                             Birth weights                               Alaska                                              Untreated US states
  2016                                       Oloomi[@R37]               Paid family leave                          Infant health outcomes                      California                                          Untreated US states
  2016                                       Basu[@R38]                 Welfare reforms                            Healthcare utilisation                      Single mothers in the USA                           Married mothers and single women in the USA
  2015                                       Grossman[@R39]             Urban empowerment zones (UEZs)             Fertility and mental health outcomes        UEZ in Chicago, New York and Philadephia            Unsuccessful applicants for UEZ status in US cities

BMI, body mass index; OECD, Organisation for Economic Co-operation and Development.

The majority of the studies examined the impact of interventions imposed at a US state or national level, such as welfare and health system reforms, legislation, taxation or industry regulation, for which randomisation would be impractical. A few studies sought to identify the effects of other population-wide exposures such as climate or political regime change. Most studies focused on a single 'treated unit' where the change took place, and SCM was used in order to select a counterfactual with a good preimplementation fit for the single unit. We cannot be sure we have identified all studies using synthetic control methods particularly if they have used alternative terminology (ie, not 'synthetic control') and have not referred to the Abadie *et al* papers.[@R1]

Steps in conducting an SCM study {#s3b}
--------------------------------

The basic steps of the approach are:Ensure the theory behind the intervention is well understood. Develop or present a conceptual model to make the theory transparent. This allows appropriate independent variables and possible confounding variables (collectively referred to hereafter as 'predictor variables' in line with Abadie *et al* [@R1] to be included in the analysis. It also allows researchers to ensure areas that have also been exposed to a similar intervention are excluded from the pool of potential controls (the 'donor pool') (see [table 2](#T2){ref-type="table"} for key assumptions of SCM).Identify potential control units. It is essential for the credibility of the method that the donor pool only contains units that are similar to the treated unit in aspects important to the outcome (see [box 1](#B1){ref-type="boxed-text"}).Develop the synthetic control. An optimisation procedure using the outcome variables from the potential control areas and any other predictor variables identified (see [box 2](#B2){ref-type="boxed-text"}) selects the best weighting of units from the donor pool to create a synthetic control. The optimisation procedure minimises the difference between the outcome of interest in the treated unit in the preintervention period and the synthetic control. The difference is measured by the root mean square prediction error (RMSPE).Run outcome analysis. Once the composition of the synthetic control has been established using only preintervention data, the postintervention data can be added and the outcome analysis run.Present results. If the intervention has had an effect this should be visible from a graph comparing the postintervention outcome with the weighted control outcome (ie, the 'synthetic control' outcome).Run robustness checks. Placebo analysis can be used as a falsification test as traditional statistical inference is inappropriate in situations where there are small numbers of treated and control units and because units are not sampled probabilistically. Placebo analysis involves performing the analysis as if other units in the donor pool were the treated unit to generate a distribution of effect estimates. If the intervention is the cause of the observed effect, then the gap between the treated and its synthetic control outcome should be largest for the actual treated unit.

###### 

Key assumptions of synthetic control methodology

  Assumption                                                                                            Assessment
  ----------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1\. Treated units and potential control units in the donor pool are similar.                          Similar levels in variables known to influence outcome variable (see [box 1](#B1){ref-type="boxed-text"} for objective and subjective elements of this assessment).
  2\. There is no contamination -- spillover of effects of intervention into potential control units.   Based on background knowledge of researchers.
  3\. No external shocks in potential control units.                                                    Based on background knowledge of researchers informed by review of trends in outcome variable.

A further useful step is to compare the synthetic control-based estimates to effect estimates obtained using other methods. A number of published SCM studies make such comparisons, most often with DiD methods[@R6] and also with pre and post approaches,[@R8] propensity score matching[@R5] and lagged dependent variable regression.[@R40] Ideally, the comparisons should be prespecified, and the likely biases of each approach made explicit.Box 1Similarity of the treated and potential control unitsIn assessing the *similarity* of the potential control units there are subjective and objective aspects.The subjective aspects are:Although the choice of predictor variables should be driven by existing theory or a conceptual model, there remains subjectivity in the choice of time periods to include.The choice of the donor pool (whether it is appropriate to include, eg, all countries of the world, all states of the USA, just economically developed countries, countries of a similar population size and so on).The limits of predictor variables that would indicate whether a potential control unit should be included or excluded from the donor pool (although this also may be driven by theory or a researcher-developed conceptual model).The objective aspect is:The systematic estimation of the weights used to construct the synthetic control from the units in the donor pool.Clearly, the subjective aspects are important in this method. It is essential for the researcher to be happy that the control units within the donor pool are sufficiently similar to the treated unit. If this is the case, then a weighted combination of any of the units in the donor pool should be a credible counterfactual for the treated unit. Box 2How synthetic control methodology (SCM) worksThe parameter of interest is the intervention effect for the treated unit, which is the difference between the outcome variable in the treated unit and the outcome variable in the synthetic control (SC) unit postintervention.In order to construct a SC, data are required for the treated unit and for a number of similar units. The minimum data required is the outcome variable of interest for both treated and potential controls over at least one time point before and after the intervention, though in practice considerably more time points will be needed in order to improve the credibility of the result.A counterfactual SC is constructed by weighting control units, such that the level and trend of the preintervention SC most closely matches the treated unit. SC aims to minimise the difference in the preintervention period in the predictors included between the intervention unit and a weighted average of control units. Predictors include preintervention values of the outcome as well as other important variables. The weights applied to different countries are based on those that minimise the difference (based on achieving the smallest root mean square prediction error). It is also usual to check that the preintervention trend in the outcome for the synthetic comparison closely matches that of the intervention. The usual default is to limit the individual country weights to being between 0 and 1 (with the total of the weights being 1) as weights outside this range would indicate extrapolationAlternative approaches to the regression-based weighting of predictor variables are available, including researcher specified predictor variable weightings and simultaneous optimisation of predictor weights and control unit weights.Once the weighting of the SC has been determined for the preintervention period, it is used to construct a counterfactual trend for the outcome in the postimplementation period. The weighting of the potential control units is the same over time. The difference between this counterfactual and the actual trend for the treated unit represents the estimated intervention effect.Technical references are given in online [supplementary material 4](#SP5){ref-type="supplementary-material"}. 10.1136/jech-2017-210106.supp5Supplementary file 5

Advantages, assumptions and limitations of SCM {#s3c}
----------------------------------------------

SCM has several advantages over alternative approaches to evaluating population health interventions. First, it offers an approach suitable when there is a small number of treated units and control units, which is often the case when population-level health interventions are being evaluated. Second, unlike DiD approaches, SCM does not rely on parallel preimplementation trends. Given that it is sometimes difficult to establish whether the parallel trends assumption is met, this method provides a useful supplementary method to DiD. Finally, SCM allows for unmeasured time-varying confounders, whereas DiD only allows for measured time-varying confounders. Any known time-varying confounder can be included in a DiD analysis as a time series variable. However, assuming the SC was constructed from a pool of similar units and a good fit was achieved over a sufficient period of time in the preimplementation period, the SCM accounts for both observed and unobserved time-varying confounding that might impact on the outcome of interest. Abadie *et al* assert that this is based on the 'intuition' that 'only units that are alike in both observed and unobserved determinants of the outcome variable as well as in the effect of those determinants on the outcome variable should produce similar trajectories of the outcome variable over extended periods of time'.[@R3]

However, the credibility of the result relies on achieving a good preimplementation fit for the outcome of interest between treated unit and synthetic control, which is difficult if the treated unit is an outlier. It is also critical that the synthetic control is built from a pool of potential controls that are similar to the treated unit. There is currently no consensus on what constitutes a 'good fit' or how to judge similarity. Other assumptions necessary to the success of the method are that there are no 'shocks', that is, other events that might differentially affect the outcome of interest in the treated unit or the potential control units in either the preintervention or postintervention period and that there is no 'contamination' or spillover of the effect of the intervention into control units. These assumptions are also made by DiD approaches.

A limitation of SCM is that traditional statistical inference is inappropriate when there are small number of treated and control units (as is the case in many country and state level studies) and the fact that units are not sampled probabilistically. Alternative falsification tests have been suggested and two approaches are set out in the case study. Other approaches are being developed.[@R6] Data availability in a consistent form across treated and control units may also prove to be a hurdle to the widespread adoption of the method.

Direct comparisons of SCM with other methods have produced mixed results. O'Neill *et al* [@R40] compared the performance of SCM against regression with lagged dependent variables and a hybrid matching/DiD approach in a study of pay for performance in UK healthcare. They concluded that SCM outperformed DiD when the parallel trends assumption was not met and that regression with lagged dependent variables outperformed SCM in most situations. They recommended the use of multiple methods. Online [supplementary material 4](#SP5){ref-type="supplementary-material"} includes an example of a study that compared SCM with a propensity score-based weighting approach in the same context as Abadie *et al*'s study.[@R2] The authors preferred the propensity score-based weighting method over SCM as it used familiar regression techniques, could be implemented using any basic statistical software and allowed greater flexibility in number of treated units and treatment effect estimators.

Conclusion {#s4}
==========

SCM is a valuable addition to the range of approaches for improving causal inference in the evaluation of population level health interventions when a randomised trial is impractical. It has certain advantages over other more widely used approaches and is one of a small number of methods that may control for unmeasured time-varying confounders. Like all methods that draw causal inferences from observational data, SCM requires a number of assumptions and its applicability is limited by the requirement for series of outcome and covariate data on both the treated unit and a suitable pool of untreated comparison units. Wider use of SCM, ideally alongside other more established methods, will help to develop a better understanding of its strengths and limitations.

###### What is already known on this subject

-   The synthetic control method can be used to evaluate population level health interventions.

-   It uses a weighted combination of potential control units to act as a counterfactual (ie, what would have happened in the treated unit without the intervention).

-   Potential control units must be similar to the treated unit and must not have been exposed to the intervention or have suffered other external shocks.

-   It does not need an assumption of parallel trends like the difference in difference approach.

###### What this study adds

-   A non-technical introduction to the method.

-   A step-by-step guide to the implementation of the method with data and syntax provided.

-   Examples of application to date of the method in health research.

-   Reference to technical sources.
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